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We diagnosed 400 possible IgM-positive cases of 
chikungunya virus in Bo, Sierra Leone, during July 2012–
January 2013 by using lateral flow immunoassays. Cases 
detected likely represent only a small fraction of total cases. 
Further laboratory testing is required to confirm this out-
break and characterize the virus.
Outbreaks of infection with chikungunya virus (CHIKV), an alphavirus that is transmitted by bites 
of infected Aedes spp. mosquitoes, were frequent in sub-
Saharan Africa and southern and Southeast Asia during the 
1950s–1970s, but the infection largely disappeared in the 
1980s; only sporadic cases were observed (1). The virus re-
emerged in the early 2000s; major outbreaks were reported 
in Kenya, some island nations in the Indian Ocean, and sev-
eral countries in Asia (2,3).
The primary symptoms of CHIKV infection are high 
fever (>38.5°C [102°F]) and severe pain in the distal joints 
of the extremities or the lumbar spine. A maculopapular 
rash, sensorineural impairment, severe headache, and other 
nonspecific symptoms may also occur. Symptoms usually 
resolve within 1–2 weeks  after onset of fever, but for a 
sizeable proportion of patients, arthralgia and arthritis be-
come chronic and pain persists for years (2,3).
A nationwide serosurvey in Sierra Leone in 1972 de-
tected cases of CHIKV infection throughout the country 
(4), but we are not aware of any cases reported since the 
mid-1970s. Two recent developments made reemergence 
appear imminent. First, outbreaks of reemerging CHIKV 
have been reported in neighboring Guinea (5) and in Sen-
egal (6). Second, recent yellow fever cases in Sierra Leone 
have shown that Aedes spp. mosquito–borne infections are 
common (7). Thus, it was not surprising when we initiated 
an infectious disease surveillance study in July 2012 in the 
city of Bo, in Southern Province, Sierra Leone, that we 
detected possible chikungunya virus infections. We report 
initial results of our investigation.
The Study
On July 7, 2012, the Mercy Hospital Research Labo-
ratory (MHRL) in Bo, Sierra Leone, initiated a 1-year 
infectious disease surveillance program to identify the 
diversity of pathogens causing febrile illness in the city. 
A tiered analysis approach was used. First, all specimens 
from febrile study participants were tested for ≈12 infec-
tions with various pathogens, including CHIKV, by com-
mercially available test kits. Specimens that showed nega-
tive results in this first round of testing were further tested 
by using cultures, multiplex PCR, and resequencing patho-
gen microarrays. The research protocol was approved by 
Njala University, George Mason University, the Liverpool 
School of Tropical Medicine, the US Naval Research Lab-
oratory, and the Sierra Leone Ethics and Scientific Review 
Committee.
During July 7, 2012–January 10, 2013, MHRL con-
ducted first-tier lateral flow immunoassay (LFI) tests of 
blood samples from all 932 outpatients >5 years of age who 
had been clinically examined at the hospital, were found to 
have febrile illness, and consented to having blood drawn 
for laboratory testing. LFI test kits (SD Bioline; Standard 
Diagnostics, Inc., Seoul, South Korea) were used for diag-
nosis of IgM against CHIKV; IgG and IgM against den-
gue virus and hepatitis A virus; hepatitis B virus surface 
antigen, hepatitis C virus, HIV-1/2, and antibodies against 
these viruses; and IgG and IgM against Leptospira spp., 
Salmonella enterica Serovar typhi, and syphilis.
Most patients reported that they had sought medical 
care within several days after the onset of their febrile ill-
nesses. Levels of IgM against CHIKV are usually detect-
able by immunochromatographic methods within a few 
days after infection and persist for ≈3–4 months (1,2). The 
LFI test kits for CHIKV were reported by the manufac-
turer to have a sensitivity of 97.1% and a specificity of 
91.1% compared with those of ELISA (8). An independent 
evaluation found a sensitivity of 50.8% and a specificity of 
89.2% for the kits; sensitivity ranged from 40.9% 1–5 days 
after onset of illness to 65.4% 16–20 days after onset (9). 
Specificity decreases after the first week (10).
More than half of the cases tested during the first 
week of the surveillance program were positive by LFI 
for CHIKV. Thus, we notified the Sierra Leone Ministry 
of Health and Sanitation of a possible CHIKV outbreak. 
By January 10, 2013,  400 (42.9%) of 932 febrile patients 
were positive by LFI for CHIKV (Figure 1). Ages of the 
400 CHIKV IgM-positive patients ranged from 6 years to 
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85 years; 172 (43.0%) were male patients. Of these 400 
patients, 220 (55.0%) reported arthralgia, 189 (47.3%) 
chills, and 156 (39.0%) headaches. Co-infections were 
common; 92 (23.0%.) were co-infected with malaria, 37 
(9.3%) with HIV, 33 (8.3%) with hepatitis B virus, and 
smaller numbers with hepatitis A, hepatitis C, tuberculosis, 
typhoid, and syphilis. Four CHIKV-positive samples were 
also positive for dengue.
On July 28, MHRL launched an Ushahidi-based web-
site (www.ushahidi.com) to compile case reports. Details 
about the patients who were positive for CHIKV were up-
loaded to the MHRL website (www.mhrlsl.com/GIA/usha-
hidi) and, if possible, were geolocated on an open street 
map (www.openstreetmap.org) that linked to a map of 
Bo created by MHRL for health research purposes (11). 
The map showed that the cases were located throughout 
Bo (Figure 2). Of the 400 LFI-positive case-patients, 319 
(79.8%) could be mapped; the remainder did not provide a 
home street address on the laboratory patient information 
form. However, the sample was not population-based be-
cause Mercy Hospital is 1 of several hospitals serving Bo, 
so a city-wide attack rate could not be determined.
Results of attempts by the US Naval Research Lab-
oratory to confirm the LFI results by using semi-nested 
reverse transcription PCR on fast technique for analysis of 
nucleic acid–preserved samples were inconclusive, pos-
sibly because of genetic sequence variation from well-
characterized strains or because of the timing of specimen 
collections. Viral loads for humans with CHIKV infection 
decrease after the second day of symptoms, and viral titers 
may be low after the fifth day (12,13). Because CHIKV 
nucleic acids are only detectable in serum for a few days, 
reverse transcription PCR results are often discordant with 
those of serologic (IgM and IgG) assays. Confirmation that 
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Figure 1. Weekly number of 
IgM-positive chikungunya virus 
test results at Mercy Hospital 
Research Laboratory, Bo, 
Sierra Leone, July 7, 2012–
January 4, 2013. 
Figure 2. Residence 
locations for IgM-positive 
cases of infection with 
chikungunya virus, Bo, 
Sierra Leone, July 7, 
2012–January 4, 2013. 
an outbreak occurred is dependent on isolation of the vi-
rus, followed by molecular characterization, full-genome 
sequencing, and phylogenetic mapping.
Conclusions
Our results suggest that an outbreak of chikungunya vi-
rus occurred in Sierra Leone. The exact time of the reemer-
gence of this virus cannot be pinpointed, but retrospective 
analyses of outpatient charts suggested that, on the basis of 
syndromic criteria, the first cases occurred in January 2012 
and the outbreak peaked during the rainy season in 2012. 
Other outbreaks reported in central and west Africa have 
also occurred during the rainy season, which is typical for 
Aedes spp. mosquito–borne infections (6,14,15). Because 
Mercy Hospital serves only a relatively small proportion of 
the residents of Bo, the cases detected likely represent only 
a small fraction of the total cases that have occurred. Fur-
ther study will be required to confirm the laboratory results 
and, if further investigation is warranted, to document the 
extent of the outbreak.
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